Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 121 - 130 of 1824 shown below

  • Kalfakakou, V

    K Charalabopoulos, A Kotsalos, A Batistatou, A Charalabopoulos, P Vezyraki, D Peschos, V Kalfakakou and A Evangelou

    Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA

    advance online publication, 2006-08-01 00:00:00.000;

    doi:10.1038/sj.bjc.6603292

    Abstract | Full article | PDF

  • Kalff, V

    J Cebon, M Findlay, C Hargreaves, M Stockler, P Thompson, M Boyer, S Roberts, A Poon, A M Scott, V Kalff, G Garas, A Dowling, D Crawford, J Ring, R Basser, A Strickland, G Macdonald, M Green, A Nowak, B Dickman, H Dhillon and V Gebski

    Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

    doi:10.1038/sj.bjc.6603674

    Abstract | Full article | PDF

  • Kalifa, C

    N Entz-Werle, A Schneider, C Kalifa, A-C Voegeli, M-D Tabone, P Marec-Berard, L Marcellin, H Pacquement, P Terrier, P Boutard, N Meyer, M-P Gaub, P Lutz, A Babin and P Oudet

    Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping

    doi:10.1038/sj.bjc.6600968

    Abstract | Full article | PDF

  • E Lacaze, V Kieffer, A Streri, C Lorenzi, E Gentaz, J-L Habrand, G Dellatolas, C Kalifa and J Grill

    Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy

    doi:10.1038/sj.bjc.6601410

    Abstract | Full article | PDF

  • V Minard-Colin, C Kalifa, J-M Guinebretiere, L Brugieres, J Dubousset, J-L Habrand, G Vassal and O Hartmann

    Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases

    doi:10.1038/sj.bjc.6601564

    Abstract | Full article | PDF

  • A C Verschuur, J Grill, A Lelouch-Tubiana, D Couanet, C Kalifa and G Vassal

    Temozolomide in paediatric high-grade glioma: a key for combination therapy?

    advance online publication, 2004-07-20 00:00:00.000;

    doi:10.1038/sj.bjc.6601997

    Abstract | Full article | PDF

  • I Boland, G Vassal, J Morizet, M-J Terrier-Lacombe, D Valteau-Couanet, C Kalifa, O Hartmann and A Gouyette

    Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

    doi:10.1038/sj.bjc.6690126

    Abstract | Full article | PDF

  • E Bouffet, M C Baranzelli, C Patte, M Portas, C Edan, P Chastagner, F Mechinaud-Lacroix and C Kalifa

    Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience

    doi:10.1038/sj.bjc.6690192

    Abstract | Full article | PDF

  • V Doireau, J Grill, M Zerah, A Lellouch-Tubiana, D Couanet, P Chastagner, J C Marchal, Y Grignon, Z Chouffai and C Kalifa

    Chemotherapy for unresectable and recurrent intramedullary glial tumours in children

    doi:10.1038/sj.bjc.6690772

    Abstract | Full article | PDF

  • Kalikaki, A

    A Kalikaki, A Koutsopoulos, M Trypaki, J Souglakos, E Stathopoulos, V Georgoulias, D Mavroudis and A Voutsina

    Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

    advance online publication, 2008-08-26 00:00:00.000;

    doi:10.1038/sj.bjc.6604629

    Abstract | Full article | PDF

  • Kalikaki, Ar

    A G Pallis, A Voutsina, Ar Kalikaki, J Souglakos, E Briasoulis, S Murray, A Koutsopoulos, M Tripaki, E Stathopoulos, D Mavroudis and V Georgoulias

    'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer

    advance online publication, 2007-11-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604068

    Abstract | Full article | PDF

  • Kalina, M

    W C M Duivenvoorden, S Vukmirovic acute-Popovic acute, M Kalina, E Seidlitz and G Singh

    Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer

    advance online publication, 2007-04-17 00:00:00.000;

    doi:10.1038/sj.bjc.6603740

    Abstract | Full article | PDF

  • Kalindjian, B

    I Chau, D Cunningham, C Russell, A R Norman, T Kurzawinski, P Harper, P Harrison, G Middleton, F Daniels, T Hickish, J Prendeville, P J Ross, B Theis, R Hull, M Walker, N Shankley, B Kalindjian, G Murray, A Gillbanks and J Black

    Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

    advance online publication, 2006-04-04 00:00:00.000;

    doi:10.1038/sj.bjc.6603058

    Abstract | Full article | PDF

  • Kalinoglou, N

    C Kosmas, N Mylonakis, G Tsakonas, G Vorgias, N Karvounis, N Tsavaris, T Daladimos, N Kalinoglou, N Malamos, T Akrivos and A Karabelis

    Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

    advance online publication, 2009-09-08 00:00:00.000;

    doi:10.1038/sj.bjc.6605305

    Abstract | Full article | PDF

  • Kalinski, T

    U Ramp, M Dejosez, C Mahotka, B Czarnotta, T Kalinski, M Wenzel, I Lorenz, M Müller, P Krammer, H E Gabbert and C D Gerharz

    Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma

    doi:10.1054/bjoc.2000.1155

    Abstract | Full article | PDF

  • Kalipciyan, M

    R Sedivy, B Wolf, M Kalipciyan, G G Steger, J Karner-Hanusch and R M Mader

    Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence

    doi:10.1054/bjoc.1999.1091

    Abstract | Full article | PDF